Gefitinib therapy for life-threatening laryngeal papillomatosis.
Bostrom
Bruce
B
Division of Pediatric Hematology Oncology, Children's Hospitals and Clinics, Minneapolis, MN 55455, USA. Bruce.Bostrom@childrenshc.org
Sidman
James
J
Marker
Stephen
S
Lander
Timothy
T
Drehner
Dennis
D
D000293:Adolescent; D000998:Antiviral Agents / Q000627:therapeutic use; D001999:Bronchoscopy; D066246:ErbB Receptors / Q000037:antagonists & inhibitors; D000077156:Gefitinib; D006801:Humans; D007822:Laryngeal Neoplasms / Q000188:drug therapy* / Q000601:surgery / Q000821:virology; D008297:Male; D010212:Papilloma / Q000188:drug therapy* / Q000601:surgery / Q000821:virology; D030361:Papillomavirus Infections / Q000150:complications*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011799:Quinazolines / Q000627:therapeutic use*; D012008:Recurrence; D016896:Treatment Outcome
D000998:Antiviral Agents; D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D066246:ErbB Receptors; D000077156:Gefitinib